Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Short [paid promotional message] Interview with Roger

<< Previous

Bullboard Posts

Next >>

Comment by wildbird1on Aug 20, 2024 9:09am

307 Views

Post# 36187515

RE:Short [paid promotional message] Interview with Roger

Thank's Eoganacht...Great video...

At the 3.37 time R.Dumoulin said.
'' Our duration of response(44%CR at 450 days), has been above and superior to any FDA approved drugs''.

He didn't say superior to some FDA approved drugs.
No! He said superior to any (all) FDA approved drugs.

Wow! You have to wonder what will be the $value of a big pharma deal, for a treatment(TLT-Ruvidar) 100% safe and superior to all the FDA approved treatments for BCG resistant patients.

The number of shares traded each days seem to drop..look like nobody want to sell and be without their TLT shares before the big news come.

I love my TLT shares.